Biomet decides to explore options for spinning out its 3i dental devices division, following Abbott's lead and Goldman Sachs' advice to another device maker
In a growing trend among device makers, Biomet Inc.announced that it's exploring strategic options to spin out its 3i dental devices division.
The company is just testing the waters and a split isn't guaranteed, but if completed the move will follow in some notable footsteps.
Abbott (NYSE:ABT) has met with mixed reactions over the last few months after deciding to carve out its research pharmaceuticals business into a separate firm calle...
